Cargando…

Human platelet interaction with E. coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4

Platelets have a major role in clotting activation and contribute to the innate immune response during systemic infections. Human platelets contain tissue factor (TF) and express functional Toll-like receptor 4 (TLR4). However, the role of TLR4 in triggering the procoagulant properties of platelets,...

Descripción completa

Detalles Bibliográficos
Autores principales: Matus, Valeria, Valenzuela, J. Guillermo, Hidalgo, Patricia, Pozo, L. María, Panes, Olga, Wozniak, Aniela, Mezzano, Diego, Pereira, Jaime, Sáez, Claudia G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619753/
https://www.ncbi.nlm.nih.gov/pubmed/28957360
http://dx.doi.org/10.1371/journal.pone.0185431
_version_ 1783267458432368640
author Matus, Valeria
Valenzuela, J. Guillermo
Hidalgo, Patricia
Pozo, L. María
Panes, Olga
Wozniak, Aniela
Mezzano, Diego
Pereira, Jaime
Sáez, Claudia G.
author_facet Matus, Valeria
Valenzuela, J. Guillermo
Hidalgo, Patricia
Pozo, L. María
Panes, Olga
Wozniak, Aniela
Mezzano, Diego
Pereira, Jaime
Sáez, Claudia G.
author_sort Matus, Valeria
collection PubMed
description Platelets have a major role in clotting activation and contribute to the innate immune response during systemic infections. Human platelets contain tissue factor (TF) and express functional Toll-like receptor 4 (TLR4). However, the role of TLR4 in triggering the procoagulant properties of platelets, upon challenge with bacteria, is yet unknown. Our hypothesis is that E. coli O111-TLR4 interaction activates platelets and elicits their procoagulant activity. We demonstrated that the strain, but not ultrapure LPS, increased surface P-selectin expression, platelet dependent TF procoagulant activity (TF-PCA) and prompted a faster thrombin generation (TG). Blockade of TLR4 resulted in decreased platelet activation, TF-PCA and TG, revealing the participation of this immune receptor on the procoagulant response of platelets. Our results provide a novel mechanism by which individuals with bacterial infections would have an increased incidence of blood clots. Furthermore, the identification of platelet TF and TLR4 as regulators of the effect of E. coli O111 might represent a novel therapeutic target to reduce the devastating consequences of the hemostatic disorder during sepsis.
format Online
Article
Text
id pubmed-5619753
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-56197532017-10-17 Human platelet interaction with E. coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4 Matus, Valeria Valenzuela, J. Guillermo Hidalgo, Patricia Pozo, L. María Panes, Olga Wozniak, Aniela Mezzano, Diego Pereira, Jaime Sáez, Claudia G. PLoS One Research Article Platelets have a major role in clotting activation and contribute to the innate immune response during systemic infections. Human platelets contain tissue factor (TF) and express functional Toll-like receptor 4 (TLR4). However, the role of TLR4 in triggering the procoagulant properties of platelets, upon challenge with bacteria, is yet unknown. Our hypothesis is that E. coli O111-TLR4 interaction activates platelets and elicits their procoagulant activity. We demonstrated that the strain, but not ultrapure LPS, increased surface P-selectin expression, platelet dependent TF procoagulant activity (TF-PCA) and prompted a faster thrombin generation (TG). Blockade of TLR4 resulted in decreased platelet activation, TF-PCA and TG, revealing the participation of this immune receptor on the procoagulant response of platelets. Our results provide a novel mechanism by which individuals with bacterial infections would have an increased incidence of blood clots. Furthermore, the identification of platelet TF and TLR4 as regulators of the effect of E. coli O111 might represent a novel therapeutic target to reduce the devastating consequences of the hemostatic disorder during sepsis. Public Library of Science 2017-09-28 /pmc/articles/PMC5619753/ /pubmed/28957360 http://dx.doi.org/10.1371/journal.pone.0185431 Text en © 2017 Matus et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Matus, Valeria
Valenzuela, J. Guillermo
Hidalgo, Patricia
Pozo, L. María
Panes, Olga
Wozniak, Aniela
Mezzano, Diego
Pereira, Jaime
Sáez, Claudia G.
Human platelet interaction with E. coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4
title Human platelet interaction with E. coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4
title_full Human platelet interaction with E. coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4
title_fullStr Human platelet interaction with E. coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4
title_full_unstemmed Human platelet interaction with E. coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4
title_short Human platelet interaction with E. coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4
title_sort human platelet interaction with e. coli o111 promotes tissue-factor-dependent procoagulant activity, involving toll like receptor 4
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619753/
https://www.ncbi.nlm.nih.gov/pubmed/28957360
http://dx.doi.org/10.1371/journal.pone.0185431
work_keys_str_mv AT matusvaleria humanplateletinteractionwithecolio111promotestissuefactordependentprocoagulantactivityinvolvingtolllikereceptor4
AT valenzuelajguillermo humanplateletinteractionwithecolio111promotestissuefactordependentprocoagulantactivityinvolvingtolllikereceptor4
AT hidalgopatricia humanplateletinteractionwithecolio111promotestissuefactordependentprocoagulantactivityinvolvingtolllikereceptor4
AT pozolmaria humanplateletinteractionwithecolio111promotestissuefactordependentprocoagulantactivityinvolvingtolllikereceptor4
AT panesolga humanplateletinteractionwithecolio111promotestissuefactordependentprocoagulantactivityinvolvingtolllikereceptor4
AT wozniakaniela humanplateletinteractionwithecolio111promotestissuefactordependentprocoagulantactivityinvolvingtolllikereceptor4
AT mezzanodiego humanplateletinteractionwithecolio111promotestissuefactordependentprocoagulantactivityinvolvingtolllikereceptor4
AT pereirajaime humanplateletinteractionwithecolio111promotestissuefactordependentprocoagulantactivityinvolvingtolllikereceptor4
AT saezclaudiag humanplateletinteractionwithecolio111promotestissuefactordependentprocoagulantactivityinvolvingtolllikereceptor4